Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balakrishna Pai

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosidesS Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapyS Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Biomaterials|June 24, 2015
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubesSangho Lee, Chandra M Valmikinathan, Jaemin Byun, et al.
Nature Materials|February 18, 2014
Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibresAnjana Jain, Martha Betancur, Gaurangkumar D Patel, et al.
Antiviral Chemistry & Chemotherapy|July 15, 2003
N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activityJunxing Shi, Judy S Mathew, Phillip M Tharnish, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosidesS Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapyS Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Biomaterials|June 24, 2015
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubesSangho Lee, Chandra M Valmikinathan, Jaemin Byun, et al.
Nature Materials|February 18, 2014
Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibresAnjana Jain, Martha Betancur, Gaurangkumar D Patel, et al.
Antiviral Chemistry & Chemotherapy|July 15, 2003
N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activityJunxing Shi, Judy S Mathew, Phillip M Tharnish, et al.
Pageof 4